ED vs RCUS · P/E 18, rev $15.26B vs rev $258.0M
Consolidated Edison Inc (ED) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the ED and RCUS stock pages for the full models.
Not investment advice.